673 related articles for article (PubMed ID: 31239661)
21. Oleanolic acid-loaded PLGA-TPGS nanoparticles combined with heparin sodium-loaded PLGA-TPGS nanoparticles for enhancing chemotherapy to liver cancer.
Gao M; Xu H; Bao X; Zhang C; Guan X; Liu H; Lv L; Deng S; Gao D; Wang C; Tian Y
Life Sci; 2016 Nov; 165():63-74. PubMed ID: 27640889
[TBL] [Abstract][Full Text] [Related]
22. Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP.
Shyu MH; Kao TC; Yen GC
J Agric Food Chem; 2010 May; 58(10):6110-8. PubMed ID: 20415421
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
Dong X; Liu F; Li M
Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo mechanism of hepatocellular carcinoma inhibition by β-TCP nanoparticles.
Liu L; Dai H; Wu Y; Li B; Yi J; Xu C; Wu X
Int J Nanomedicine; 2019; 14():3491-3502. PubMed ID: 31190806
[No Abstract] [Full Text] [Related]
25. Cisplatin-loaded polymeric nanoparticles: characterization and potential exploitation for the treatment of non-small cell lung carcinoma.
Shi C; Yu H; Sun D; Ma L; Tang Z; Xiao Q; Chen X
Acta Biomater; 2015 May; 18():68-76. PubMed ID: 25707922
[TBL] [Abstract][Full Text] [Related]
26. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b.
Zhuang Q; Zhou T; He C; Zhang S; Qiu Y; Luo B; Zhao R; Liu H; Lin Y; Lin Z
J Exp Clin Cancer Res; 2016 Apr; 35():67. PubMed ID: 27074866
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
28. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
29. Molecular evidence for better efficacy of hypocrellin A and oleanolic acid combination in suppression of HCC growth.
Wang L; Wang J; Cao Y; Li W; Wang Y; Xu J; Xu G
Eur J Pharmacol; 2019 Jan; 842():281-290. PubMed ID: 30391347
[TBL] [Abstract][Full Text] [Related]
30. Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo.
Hui F; Qin X; Zhang Q; Li R; Liu M; Ren T; Zhao M; Zhao Q
Biomed Pharmacother; 2019 Jan; 109():2365-2374. PubMed ID: 30551496
[TBL] [Abstract][Full Text] [Related]
31. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3.
Ku JM; Hong SH; Kim HI; Kim MJ; Kim SK; Kim M; Choi SY; Park J; Kim HK; Kim JH; Seo HS; Shin YC; Ko SG
Phytomedicine; 2020 Jan; 66():153109. PubMed ID: 31790894
[TBL] [Abstract][Full Text] [Related]
32. Oleanolic acid-conjugated human serum albumin nanoparticles encapsulating doxorubicin as synergistic combination chemotherapy in oropharyngeal carcinoma and melanoma.
Kumbham S; Paul M; Itoo A; Ghosh B; Biswas S
Int J Pharm; 2022 Feb; 614():121479. PubMed ID: 35041911
[TBL] [Abstract][Full Text] [Related]
33. Oleanolic Acid Loaded PEGylated PLA and PLGA Nanoparticles with Enhanced Cytotoxic Activity against Cancer Cells.
Man DK; Casettari L; Cespi M; Bonacucina G; Palmieri GF; Sze SC; Leung GP; Lam JK; Kwok PC
Mol Pharm; 2015 Jun; 12(6):2112-25. PubMed ID: 25881668
[TBL] [Abstract][Full Text] [Related]
34. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
Nasr M; Nafee N; Saad H; Kazem A
Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
[TBL] [Abstract][Full Text] [Related]
35. Cotreatment with sorafenib and oleanolic acid induces reactive oxygen species-dependent and mitochondrial-mediated apoptotic cell death in hepatocellular carcinoma cells.
Liese J; Hinrichs TM; Lange M; Fulda S
Anticancer Drugs; 2019 Mar; 30(3):209-217. PubMed ID: 30640794
[TBL] [Abstract][Full Text] [Related]
36. Multilayer-Coated Liquid Crystalline Nanoparticles for Effective Sorafenib Delivery to Hepatocellular Carcinoma.
Thapa RK; Choi JY; Poudel BK; Hiep TT; Pathak S; Gupta B; Choi HG; Yong CS; Kim JO
ACS Appl Mater Interfaces; 2015 Sep; 7(36):20360-8. PubMed ID: 26315487
[TBL] [Abstract][Full Text] [Related]
37. Daurisoline inhibits hepatocellular carcinoma progression by restraining autophagy and promoting cispaltin-induced cell death.
Xue L; Liu P
Biochem Biophys Res Commun; 2021 Jan; 534():1083-1090. PubMed ID: 33213840
[TBL] [Abstract][Full Text] [Related]
38. PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
Singh M; Bhatnagar P; Mishra S; Kumar P; Shukla Y; Gupta KC
Int J Nanomedicine; 2015; 10():6789-809. PubMed ID: 26586942
[TBL] [Abstract][Full Text] [Related]
39. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines.
Xu SP; Sun GP; Shen YX; Peng WR; Wang H; Wei W
Acta Pharmacol Sin; 2007 Jun; 28(6):869-78. PubMed ID: 17506946
[TBL] [Abstract][Full Text] [Related]
40. Olean-28,13b-olide 2 plays a role in cisplatin-mediated apoptosis and reverses cisplatin resistance in human lung cancer through multiple signaling pathways.
Zhu B; Ren C; Du K; Zhu H; Ai Y; Kang F; Luo Y; Liu W; Wang L; Xu Y; Jiang X; Zhang Y
Biochem Pharmacol; 2019 Dec; 170():113642. PubMed ID: 31541631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
